沙门氏菌对抗生素的防御机制综述。

Frontiers in antibiotics Pub Date : 2024-09-17 eCollection Date: 2024-01-01 DOI:10.3389/frabi.2024.1448796
Anuradha Jeewantha Punchihewage-Don, Priyanka Nilmini Ranaweera, Salina Parveen
{"title":"沙门氏菌对抗生素的防御机制综述。","authors":"Anuradha Jeewantha Punchihewage-Don, Priyanka Nilmini Ranaweera, Salina Parveen","doi":"10.3389/frabi.2024.1448796","DOIUrl":null,"url":null,"abstract":"<p><p><i>Salmonella</i> is a foodborne pathogenic bacterium that causes salmonellosis worldwide. Also, <i>Salmonella</i> is considered a serious problem for food safety and public health. Several antimicrobial classes including aminoglycosides, tetracyclines, phenols, and β-Lactams are used to treat <i>Salmonella</i> infections. Antibiotics have been prescribed for decades to treat infections caused by bacteria in human and animal healthcare. However, intensive use of antibiotics resulted in antibiotic resistance (AR) among several foodborne bacteria including <i>Salmonella</i>. Furthermore, multi-drug resistance (MDR) of <i>Salmonella</i> has increased dramatically. In addition to MDR <i>Salmonella</i>, extensively drug resistant (XDR) as well as pan drug resistant (PDR) <i>Salmonella</i> were reported globally. Therefore, increasing AR is becoming a serious universal public health crisis. <i>Salmonella</i> developed many mechanisms to ensure its survival against antimicrobials. The most prominent defense mechanisms against these antibiotics include enzymatic inactivation, expelling drugs from the cell through efflux pumps, altering the structure of drugs, and changing or protecting the targets of drugs. Additionally, the formation of biofilms and plasmid-mediated AR by <i>Salmonella</i>, enhancing its resistance to various antibiotics, making it a challenging pathogen in both healthcare and food industry settings. This review focuses exclusively on providing a detailed overview of the mechanisms of AR in <i>Salmonella</i>.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"3 ","pages":"1448796"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731628/pdf/","citationCount":"0","resultStr":"{\"title\":\"Defense mechanisms of <i>Salmonella</i> against antibiotics: a review.\",\"authors\":\"Anuradha Jeewantha Punchihewage-Don, Priyanka Nilmini Ranaweera, Salina Parveen\",\"doi\":\"10.3389/frabi.2024.1448796\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><i>Salmonella</i> is a foodborne pathogenic bacterium that causes salmonellosis worldwide. Also, <i>Salmonella</i> is considered a serious problem for food safety and public health. Several antimicrobial classes including aminoglycosides, tetracyclines, phenols, and β-Lactams are used to treat <i>Salmonella</i> infections. Antibiotics have been prescribed for decades to treat infections caused by bacteria in human and animal healthcare. However, intensive use of antibiotics resulted in antibiotic resistance (AR) among several foodborne bacteria including <i>Salmonella</i>. Furthermore, multi-drug resistance (MDR) of <i>Salmonella</i> has increased dramatically. In addition to MDR <i>Salmonella</i>, extensively drug resistant (XDR) as well as pan drug resistant (PDR) <i>Salmonella</i> were reported globally. Therefore, increasing AR is becoming a serious universal public health crisis. <i>Salmonella</i> developed many mechanisms to ensure its survival against antimicrobials. The most prominent defense mechanisms against these antibiotics include enzymatic inactivation, expelling drugs from the cell through efflux pumps, altering the structure of drugs, and changing or protecting the targets of drugs. Additionally, the formation of biofilms and plasmid-mediated AR by <i>Salmonella</i>, enhancing its resistance to various antibiotics, making it a challenging pathogen in both healthcare and food industry settings. This review focuses exclusively on providing a detailed overview of the mechanisms of AR in <i>Salmonella</i>.</p>\",\"PeriodicalId\":73065,\"journal\":{\"name\":\"Frontiers in antibiotics\",\"volume\":\"3 \",\"pages\":\"1448796\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731628/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in antibiotics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/frabi.2024.1448796\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in antibiotics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frabi.2024.1448796","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

沙门氏菌是一种食源性致病菌,在世界范围内引起沙门氏菌病。此外,沙门氏菌被认为是食品安全和公众健康的严重问题。包括氨基糖苷类、四环素类、酚类和β-内酰胺类在内的几种抗菌药物被用于治疗沙门氏菌感染。几十年来,抗生素一直被用于治疗人类和动物保健中由细菌引起的感染。然而,抗生素的大量使用导致包括沙门氏菌在内的几种食源性细菌产生抗生素耐药性。此外,沙门氏菌的多药耐药(MDR)急剧增加。除耐多药沙门氏菌外,全球还报告了广泛耐药沙门氏菌和泛耐药沙门氏菌。因此,日益严重的AR正在成为一种严重的全球性公共卫生危机。沙门氏菌发展了许多机制以确保其在抗菌剂中存活。针对这些抗生素最突出的防御机制包括酶失活、通过外排泵将药物从细胞中排出、改变药物结构以及改变或保护药物靶点。此外,沙门氏菌形成生物膜和质粒介导的AR,增强其对各种抗生素的耐药性,使其成为医疗保健和食品工业环境中的一种具有挑战性的病原体。这篇综述的重点是提供沙门氏菌的AR机制的详细概述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Defense mechanisms of Salmonella against antibiotics: a review.

Salmonella is a foodborne pathogenic bacterium that causes salmonellosis worldwide. Also, Salmonella is considered a serious problem for food safety and public health. Several antimicrobial classes including aminoglycosides, tetracyclines, phenols, and β-Lactams are used to treat Salmonella infections. Antibiotics have been prescribed for decades to treat infections caused by bacteria in human and animal healthcare. However, intensive use of antibiotics resulted in antibiotic resistance (AR) among several foodborne bacteria including Salmonella. Furthermore, multi-drug resistance (MDR) of Salmonella has increased dramatically. In addition to MDR Salmonella, extensively drug resistant (XDR) as well as pan drug resistant (PDR) Salmonella were reported globally. Therefore, increasing AR is becoming a serious universal public health crisis. Salmonella developed many mechanisms to ensure its survival against antimicrobials. The most prominent defense mechanisms against these antibiotics include enzymatic inactivation, expelling drugs from the cell through efflux pumps, altering the structure of drugs, and changing or protecting the targets of drugs. Additionally, the formation of biofilms and plasmid-mediated AR by Salmonella, enhancing its resistance to various antibiotics, making it a challenging pathogen in both healthcare and food industry settings. This review focuses exclusively on providing a detailed overview of the mechanisms of AR in Salmonella.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信